Key Insights

Highlights

Treatment Research

2 treatments under study, led by Observation

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Recruiting1
Unknown1

Clinical Trials (2)

Showing 2 of 2 trials
NCT07128966Recruiting

Direct to Patient Minimal Risk Biospecimen and Data Collection Research

NCT03723083UnknownPrimary

Expanded Access for CC-2001

Showing all 2 trials

Research Network

Common Treatments

  • Observation1
  • Cc20011

Active Sponsors

  • Celgene1
  • Joined Bio1

Top Investigators

Related Conditions

  • Healthy1
  • Lupus1
  • Other1
  • Chronic1
  • Celiac1

Activity Timeline